Rønn SG - Search Results

1

Regulation of pancreatic beta-cell mass and proliferation by SOCS-3.

Lindberg K, Rønn SG, Tornehave D, Richter H, Hansen JA, Rømer J, Jackerott M, Billestrup N. Lindberg K, et al. Among authors: ronn sg. J Mol Endocrinol. 2005 Oct;35(2):231-43. doi: 10.1677/jme.1.01840. J Mol Endocrinol. 2005. PMID: 16216905

2

The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells.

Rønn SG, Hansen JA, Lindberg K, Karlsen AE, Billestrup N. Rønn SG, et al. Mol Endocrinol. 2002 Sep;16(9):2124-34. doi: 10.1210/me.2002-0082. Mol Endocrinol. 2002. PMID: 12198248

3

Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.

Frobøse H, Rønn SG, Heding PE, Mendoza H, Cohen P, Mandrup-Poulsen T, Billestrup N. Frobøse H, et al. Among authors: ronn sg. Mol Endocrinol. 2006 Jul;20(7):1587-96. doi: 10.1210/me.2005-0301. Epub 2006 Mar 16. Mol Endocrinol. 2006. PMID: 16543409

4

Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells.

Bruun C, Heding PE, Rønn SG, Frobøse H, Rhodes CJ, Mandrup-Poulsen T, Billestrup N. Bruun C, et al. Among authors: ronn sg. Mol Cell Endocrinol. 2009 Nov 13;311(1-2):32-8. doi: 10.1016/j.mce.2009.07.019. Epub 2009 Jul 28. Mol Cell Endocrinol. 2009. PMID: 19643162

5

Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.

Karlsen AE, Rønn SG, Lindberg K, Johannesen J, Galsgaard ED, Pociot F, Nielsen JH, Mandrup-Poulsen T, Nerup J, Billestrup N. Karlsen AE, et al. Among authors: ronn sg. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12191-6. doi: 10.1073/pnas.211445998. Epub 2001 Oct 2. Proc Natl Acad Sci U S A. 2001. PMID: 11593036 Free PMC article.

6

Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.

Karlsen AE, Heding PE, Frobøse H, Rønn SG, Kruhøffer M, Orntoft TF, Darville M, Eizirik DL, Pociot F, Nerup J, Mandrup-Poulsen T, Billestrup N. Karlsen AE, et al. Among authors: ronn sg. Diabetologia. 2004 Nov;47(11):1998-2011. doi: 10.1007/s00125-004-1568-3. Epub 2004 Dec 2. Diabetologia. 2004. PMID: 15578154

7

IL-1beta-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells.

Jacobsen ML, Rønn SG, Bruun C, Larsen CM, Eizirik DL, Mandrup-Poulsen T, Billestrup N. Jacobsen ML, et al. Among authors: ronn sg. Diabetologia. 2009 Feb;52(2):281-8. doi: 10.1007/s00125-008-1199-1. Epub 2008 Nov 11. Diabetologia. 2009. PMID: 19002429

8

Diabetes and suppressors of cytokine signaling proteins.

Rønn SG, Billestrup N, Mandrup-Poulsen T. Rønn SG, et al. Diabetes. 2007 Feb;56(2):541-8. doi: 10.2337/db06-1068. Diabetes. 2007. PMID: 17259405 Review. No abstract available.

9

Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection.

Rønn SG, Börjesson A, Bruun C, Heding PE, Frobøse H, Mandrup-Poulsen T, Karlsen AE, Rasschaert J, Sandler S, Billestrup N. Rønn SG, et al. Diabetologia. 2008 Oct;51(10):1873-82. doi: 10.1007/s00125-008-1090-0. Epub 2008 Jul 22. Diabetologia. 2008. PMID: 18648765

10

β-cell specific overexpression of suppressor of cytokine signalling-3 does not protect against multiple low dose streptozotocin induced type 1 diabetes in mice.

Börjesson A, Rønn SG, Karlsen AE, Billestrup N, Sandler S. Börjesson A, et al. Among authors: ronn sg. Immunol Lett. 2011 Apr 30;136(1):74-9. doi: 10.1016/j.imlet.2010.12.007. Epub 2011 Jan 13. Immunol Lett. 2011. PMID: 21237203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page